BackIbere Pharmaceuticals Overview

Ibere Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for IBER.

Quarterly SG&A Expenses

N/A

As of Sep 30, 2022

Annual SG&A Expenses (TTM)

$-94478.00

Trailing 12 months ending Sep 30, 2022

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)